person · Reporting owner
WILLIAMS DAVID PATRICK
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | executive vice president & CFO | November 13, 2023 | November 15, 2023 |
| REGIS CORPRGS · Entity 8808 | Director | September 11, 2020 | September 14, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date November 13, 2023 · Filed November 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| capital stockSEC Table I · non-derivative | Direct | 5,826 |
Ending reported balance
After 2023-11-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-13 · Sale · Disposed 3,814 · Balance 7,012 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $585.50 to $587.13. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Row 2 · 2023-11-14 · Sale · Disposed 1,186 · Balance 5,826 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $585.50 to $587.13. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
REGIS CORP
Report date September 11, 2020 · Filed September 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,004 |
Reported balance
After 2020-09-11 transaction · row 1
1 source rowRow 1 · 2020-09-11 · Sale · Disposed 40,000 · Balance 76,004 F1: Reflects the weighted average price of 40,000 shares of common stock of Issuer sold by the Reporting Person in multiple transactions on September 11, 2020 with prices ranging from $6.14 to $6.28 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the weighted average price of 40,000 shares of common stock of Issuer sold by the Reporting Person in multiple transactions on September 11, 2020 with prices ranging from $6.14 to $6.28 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2021 Filed Feb 23, 2021 20:32 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,260 | $491.34 | $619,088.40 |
DisclosureSEC source: 0001209191-21-013127 · doc4.xml · nonDerivative · entry 3 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,259 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:32 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 1,295 | $491.34 | $636,285.30 |
DisclosureSEC source: 0001209191-21-013127 · doc4.xml · nonDerivative · entry 2 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2018 through December 31, 2020, compared to a defined peer group of companies. The Company's performance ranked in the 79th percentile of that group, yielding an award of 163.2%; including the reinvestment of dividends paid during such period, the award is 164.79% of target. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:32 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 1,588 | $491.34 | $780,247.92 |
DisclosureSEC source: 0001209191-21-013127 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2018 through December 31, 2020. The actual performance of 29.1% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 16:53 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 16,815 | $471.74 Strike: $471.74 | $7,932,308.10 |
DisclosureSEC source: 0001209191-20-056300 · doc4.xml · derivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,299 Underlying: capital stock · 16,815 shares Expires 2025-10-29 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
| September 11, 2020 Filed Sep 14, 2020 17:55 UTC | REGIS CORP RGS · Entity 8808 | SaleCommon Stock | 40,000 | $6.19 | $247,600.00 |
DisclosureSEC source: 0000716643-20-000054 · wf-form4_160010612097060.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,004 F1 · price: Reflects the weighted average price of 40,000 shares of common stock of Issuer sold by the Reporting Person in multiple transactions on September 11, 2020 with prices ranging from $6.14 to $6.28 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:10 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 1,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012365 · doc4.xml · derivative · entry 7 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,880 Underlying: capital stock · 1,030 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2020 to December 31, 2022. The determination of the performance level is to be made by March 15, 2023 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2020 to December 31, 2022. The determination of the performance level is to be made by March 15, 2023 and earned shares to be delivered thereafter. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:10 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 863 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012365 · doc4.xml · derivative · entry 6 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,850 Underlying: capital stock · 863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 17, 2017 vest based on achievement of performance targets over a period of January 1, 2017 to December 31, 2019. The determination of the performance level was to be made by March 15, 2020. F5 · derivative.expiration_date: PSU's awarded February 17, 2017 vest based on achievement of performance targets over a period of January 1, 2017 to December 31, 2019. The determination of the performance level was to be made by March 15, 2020. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:10 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 863 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012365 · doc4.xml · derivative · entry 5 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,713 Underlying: capital stock · 863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 17, 2017 vest based on achievement of performance targets over a period of January 1, 2017 to December 31, 2019. The determination of the performance level was to be made by March 15, 2020. F5 · derivative.expiration_date: PSU's awarded February 17, 2017 vest based on achievement of performance targets over a period of January 1, 2017 to December 31, 2019. The determination of the performance level was to be made by March 15, 2020. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:10 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,388 | $487.90 | $677,205.20 |
DisclosureSEC source: 0001209191-20-012365 · doc4.xml · nonDerivative · entry 3 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,636 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:10 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 1,426 | $487.90 | $695,745.40 |
DisclosureSEC source: 0001209191-20-012365 · doc4.xml · nonDerivative · entry 2 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2017 through December 31, 2019, compared to a defined peer group of companies. The Company's performance ranked in the 79th percentile of that group, yielding an award of 163.2%; including the reinvestment of dividends paid during such period, the award is 165.2% of target. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:10 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 1,748 | $487.90 | $852,849.20 |
DisclosureSEC source: 0001209191-20-012365 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2017 through December 31, 2019. The actual performance of 24.29% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.5% of target. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 16:15 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 15,100 | $413.19 Strike: $413.19 | $6,239,169.00 |
DisclosureSEC source: 0001209191-19-054595 · doc4.xml · derivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,484 Underlying: capital stock · 15,100 shares Expires 2024-10-29 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 18:53 UTC | REGIS CORP RGS · Entity 8808 | GrantCommon Stock | 8,976 | $0.00 | $0.00 |
DisclosureSEC source: 0000716643-19-000071 · wf-form4_157194316078253.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,004 F1 · shares: The Reporting Person was awarded a grant of 8,976 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of RGS common stock. Read SEC document |
| August 12, 2019 Filed Aug 12, 2019 17:14 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 17,979 | $430.80 | $7,745,353.20 |
DisclosureSEC source: 0001209191-19-045462 · doc4.xml · nonDerivative · entry 4 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,850 Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 17:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 20,766 | $135.85 Strike: $135.85 | $2,821,061.10 |
DisclosureSEC source: 0001209191-19-045462 · doc4.xml · derivative · entry 6 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,384 Underlying: capital stock · 20,766 shares Expires 2021-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/04/2017 Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 17:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 8,000 | $157.36 Strike: $157.36 | $1,258,880.00 |
DisclosureSEC source: 0001209191-19-045462 · doc4.xml · derivative · entry 5 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,150 Underlying: capital stock · 8,000 shares Expires 2020-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/6/2016. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 17:14 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 17,787 | $426.99 | $7,594,871.13 |
DisclosureSEC source: 0001209191-19-045462 · doc4.xml · nonDerivative · entry 3 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,829 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 17:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 20,766 | $135.85 | $2,821,061.10 |
DisclosureSEC source: 0001209191-19-045462 · doc4.xml · nonDerivative · entry 2 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 17:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 8,000 | $157.36 | $1,258,880.00 |
DisclosureSEC source: 0001209191-19-045462 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:52 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 1,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012911 · doc4.xml · derivative · entry 6 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,576 Underlying: capital stock · 1,278 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2019 to December 31, 2021. The determination of the performance level is to be made by March 15, 2022 and earned shares to be delivered thereafter F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2019 to December 31, 2021. The determination of the performance level is to be made by March 15, 2022 and earned shares to be delivered thereafter Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:52 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012911 · doc4.xml · derivative · entry 5 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,298 Underlying: capital stock · 988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019. F5 · derivative.expiration_date: PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:52 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012911 · doc4.xml · derivative · entry 4 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,286 Underlying: capital stock · 988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019. F5 · derivative.expiration_date: PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:52 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,500 | $322.40 | $483,600.00 |
DisclosureSEC source: 0001209191-19-012911 · doc4.xml · nonDerivative · entry 3 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,850 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:52 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 1,423 | $322.40 | $458,775.20 |
DisclosureSEC source: 0001209191-19-012911 · doc4.xml · nonDerivative · entry 2 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2016 through December 31, 2018, compared to a defined peer group of companies. The Company's performance ranked in the 70th percentile of that group, yielding an award of 141.7%; including the reinvestment of dividends paid during such period, the award is 144.0% of target. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:52 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 2,009 | $322.40 | $647,701.60 |
DisclosureSEC source: 0001209191-19-012911 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2016 through December 31, 2018. The actual performance of 20.52% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 203.3% of target. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 16:05 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,000 | $302.30 | $3,023,000.00 |
DisclosureSEC source: 0001209191-18-059633 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,918 Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 16:35 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 15,500 | $306.70 Strike: $306.70 | $4,753,850.00 |
DisclosureSEC source: 0001209191-18-057077 · doc4.xml · derivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,150 Underlying: capital stock · 15,500 shares Expires 2023-11-02 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019 Read SEC document |
| October 23, 2018 Filed Oct 25, 2018 14:50 UTC | REGIS CORP RGS · Entity 8808 | GrantCommon Stock | 10,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000716643-18-000064 · wf-form4_154047899734260.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,028 F1 · shares: The Reporting Person was awarded a grant of 10,167 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of RGS common stock. Read SEC document |
| May 22, 2018 Filed May 22, 2018 14:36 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 437 | $333.53 | $145,752.61 |
DisclosureSEC source: 0001209191-18-032194 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,918 F1 · kind: stock award tax obligation Read SEC document |
| May 11, 2018 Filed May 11, 2018 17:31 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,000 | $326.17 | $3,261,700.00 |
DisclosureSEC source: 0001209191-18-029459 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,355 Read SEC document |
| May 09, 2018 Filed May 9, 2018 19:11 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 17,756 | $70.30 Strike: $70.30 | $1,248,246.80 |
DisclosureSEC source: 0001209191-18-028820 · doc4.xml · derivative · entry 3 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,650 Underlying: capital stock · 17,756 shares Expires 2023-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/8/2014. Read SEC document |
| May 09, 2018 Filed May 9, 2018 19:11 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 9,858 | $317.17 | $3,126,661.86 |
DisclosureSEC source: 0001209191-18-028820 · doc4.xml · nonDerivative · entry 2 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,355 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 09, 2018 Filed May 9, 2018 19:11 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 17,756 | $70.30 | $1,248,246.80 |
DisclosureSEC source: 0001209191-18-028820 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2018 Filed May 7, 2018 19:40 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 16,000 | $157.36 Strike: $157.36 | $2,517,760.00 |
DisclosureSEC source: 0001209191-18-028279 · doc4.xml · derivative · entry 4 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,406 Underlying: capital stock · 16,000 shares Expires 2020-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: vesting in three equal annual installments commencing 11/6/2016. Read SEC document |
| May 07, 2018 Filed May 7, 2018 19:40 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,000 | $316.08 | $3,160,800.00 |
DisclosureSEC source: 0001209191-18-028279 · doc4.xml · nonDerivative · entry 3 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,457 Read SEC document |
| May 07, 2018 Filed May 7, 2018 19:40 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 11,438 | $313.98 | $3,591,303.24 |
DisclosureSEC source: 0001209191-18-028279 · doc4.xml · nonDerivative · entry 2 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,457 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 07, 2018 Filed May 7, 2018 19:40 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 16,000 | $157.36 | $2,517,760.00 |
DisclosureSEC source: 0001209191-18-028279 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2018 Filed Apr 25, 2018 19:21 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 5,713 | $303.18 | $1,732,067.34 |
DisclosureSEC source: 0001209191-18-026046 · doc4.xml · nonDerivative · entry 4 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,895 Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:21 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 30,000 | $63.36 Strike: $63.36 | $1,900,800.00 |
DisclosureSEC source: 0001209191-18-026046 · doc4.xml · derivative · entry 5 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,406 Underlying: capital stock · 30,000 shares Expires 2022-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: exercisable in 3 equal annual installments commencing 2/17/2013. Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:21 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,000 | $301.11 | $3,011,100.00 |
DisclosureSEC source: 0001209191-18-026046 · doc4.xml · nonDerivative · entry 3 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,608 Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:21 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 16,444 | $302.72 | $4,977,927.68 |
DisclosureSEC source: 0001209191-18-026046 · doc4.xml · nonDerivative · entry 2 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,608 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:21 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 30,000 | $63.36 | $1,900,800.00 |
DisclosureSEC source: 0001209191-18-026046 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:29 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 1,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011158 · doc4.xml · derivative · entry 6 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,274 Underlying: capital stock · 1,572 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level is to be made by March 15, 2021 and earned shares delivered thereafter. F7 · derivative.expiration_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level is to be made by March 15, 2021 and earned shares delivered thereafter. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:29 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011158 · doc4.xml · derivative · entry 5 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,702 Underlying: capital stock · 1,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. F5 · derivative.expiration_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:29 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011158 · doc4.xml · derivative · entry 4 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,807 Underlying: capital stock · 1,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. F5 · derivative.expiration_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:29 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,772 | $256.29 | $454,145.88 |
DisclosureSEC source: 0001209191-18-011158 · doc4.xml · nonDerivative · entry 3 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,052 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:29 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 2,253 | $256.29 | $577,421.37 |
DisclosureSEC source: 0001209191-18-011158 · doc4.xml · nonDerivative · entry 2 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2015 through December 31, 2017, compared to a defined peer group of companies. The Company's performance ranked in the 90th percentile of that group, yielding an award of 200%; including the reinvestment of dividends paid during such period, the award is 203.9% of target. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:29 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 1,801 | $256.29 | $461,578.29 |
DisclosureSEC source: 0001209191-18-011158 · doc4.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2015 through December 31, 2017. The actual performance of 11.79% yielded an award of 159.9% of target; including the reinvestment of dividends paid during such period, the award is 163.0% of target. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 14:42 UTC | REGIS CORP RGS · Entity 8808 | PurchaseCommon Stock | 5,000 | $15.50 | $77,500.00 |
DisclosureSEC source: 0000716643-18-000014 · wf-form4_151844655690758.xml · nonDerivative · entry 1 WILLIAMS DAVID PATRICK · CIK 0001283114 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,861 F1 · price: Reflects the weighted average price of 5,000 shares of common stock of Issuer purchased by the Reporting Person in multiple transactions on February 8, 2018 with prices ranging from $15.475 to $15.50 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 29, 2017 Filed Nov 30, 2017 14:36 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 1,000 | $244.85 | $244,850.00 |
DisclosureSEC source: 0001209191-17-062968 · doc4.xml · nonDerivative · entry 4 WILLIAMS DAVID PATRICK · CIK 0001283114 · executive vice president & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,770 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.